Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic HIV Vaccination Before Structured Treatment Interruption
NCT00212888Phase 2Completed
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Apr 2004
- Primary completion
- Jul 2010
- Modality
- DNA Vaccines, Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of Remune, ALVAC-HIV vaccine in human immunodeficiency virus infection (HIV), sponsored by Ottawa Hospital Research Institute. Started Apr 2004; status: completed.
02
Drugs
RemuneALVAC-HIV vaccine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00212888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00212888.